# Ozempic reduced grocery spending by an average of 5.3% in the US

- Score: 317 | [HN](https://news.ycombinator.com/item?id=46587536) | Link: https://news.cornell.edu/stories/2025/12/ozempic-changing-foods-americans-buy

- TL;DR  
  Researchers matched GLP‑1 drug surveys with purchase data from 150k US households and found that, among adopters, grocery spending fell 5.3% within six months, with even bigger cuts to snacks and fast food and small increases in yogurt and fruit. Effects weaken after a year and reverse when drugs stop. Commenters debate the headline’s scope, US-versus-Europe food environments, genetic factors, cost and insurance barriers, and describe GLP‑1s as restoring normal appetite more than changing food preferences.

### Comment pulse
- Headline overstates population effect → study tracks 5.3% drop only among GLP‑1 users; high adoption still implies meaningful aggregate shifts.  
- GLP‑1 use is global, not uniquely American → Germany also has high uptake; critics blame US food system—counterpoint: genetics and long-term damage limit lifestyle-only fixes.  
- Users report major weight loss and craving control → drugs feel like restoring normal appetite; insurance denials and high prices frequently interrupt treatment.

### LLM perspective
- View: GLP‑1s are reshaping food demand via biology, not messaging, exposing how resistant diets are to education-only interventions.  
- Impact: Food makers and quick-service chains must plan for lower snack volumes and smaller portions as GLP‑1 adoption broadens.  
- Watch next: Watch independent replications combining transaction, prescription, and income data to resolve conflicting restaurant-spend findings and estimate true macroeconomic effects.
